Headline News about Amgen![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
Analyst Ratings for Amgen
November 18, 2022
Via Benzinga
![]()
Where Amgen Stands With Analysts
November 18, 2022
Via Benzinga
![]()
Amgen Earnings Perspective: Return On Invested Capital
November 17, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study
November 07, 2022
Via Benzinga
![]() ![]()
Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth
November 04, 2022
Via Benzinga
![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|